Boeck S - Search Results

1

Systemic treatment of advanced pancreatic cancer.

Heinemann V, Haas M, Boeck S. Heinemann V, et al. Among authors: boeck s. Cancer Treat Rev. 2012 Nov;38(7):843-53. doi: 10.1016/j.ctrv.2011.12.004. Epub 2012 Jan 4. Cancer Treat Rev. 2012. PMID: 22226241 Review.

2

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood.

Krueger K, Mayer Z, Gerckens M, Boeck S, Luppa P, Holdenrieder S. Krueger K, et al. Among authors: boeck s. Biomedicines. 2022 Sep 26;10(10):2405. doi: 10.3390/biomedicines10102405. Biomedicines. 2022. PMID: 36289665 Free PMC article.

3

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood.

Krueger K, Mayer Z, Kottmaier M, Gerckens M, Boeck S, Luppa P, Holdenrieder S. Krueger K, et al. Among authors: boeck s. Biomedicines. 2022 Oct 11;10(10):2534. doi: 10.3390/biomedicines10102534. Biomedicines. 2022. PMID: 36289796 Free PMC article.

4

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.

Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Boeck S, et al. Oncology. 2006;70(4):255-64. doi: 10.1159/000094888. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899980 Free article. Review.

5

RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.

Fahrig R, Quietzsch D, Heinrich JC, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Hänel M. Fahrig R, et al. Among authors: boeck s. Anticancer Drugs. 2006 Oct;17(9):1045-56. doi: 10.1097/01.cad.0000231472.92406.d2. Anticancer Drugs. 2006. PMID: 17001178

6

Importance of performance status for treatment outcome in advanced pancreatic cancer.

Boeck S, Hinke A, Wilkowski R, Heinemann V. Boeck S, et al. World J Gastroenterol. 2007 Jan 14;13(2):224-7. doi: 10.3748/wjg.v13.i2.224. World J Gastroenterol. 2007. PMID: 17226900 Free PMC article. Review.

7

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.

Boeck S, Weigang-Köhler K, Fuchs M, Kettner E, Quietzsch D, Trojan J, Stötzer O, Zeuzem S, Lordick F, Köhne CH, Kröning H, Steinmetz T, Depenbrock H, Heinemann V. Boeck S, et al. Ann Oncol. 2007 Apr;18(4):745-51. doi: 10.1093/annonc/mdl463. Epub 2007 Jan 17. Ann Oncol. 2007. PMID: 17229775 Free article. Clinical Trial.

8

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?

Boeck S, Schulz C, Stieber P, Holdenrieder S, Weckbach S, Heinemann V. Boeck S, et al. Onkologie. 2007 Feb;30(1-2):39-42. doi: 10.1159/000097764. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264524 Free article.

9

[Molecular-based treatment concepts in advanced pancreatic cancer].

Boeck S, Moosmann N, Stemmler HJ, Heinemann V. Boeck S, et al. Dtsch Med Wochenschr. 2007 Apr 13;132(15):818-22. doi: 10.1055/s-2007-973627. Dtsch Med Wochenschr. 2007. PMID: 17427093 Review. German. No abstract available.

10

[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].

Moosmann N, Boeck S, Heinemann V. Moosmann N, et al. Among authors: boeck s. Med Klin (Munich). 2007 Jul 15;102(7):551-62; quiz 563-4. doi: 10.1007/s00063-007-1069-5. Med Klin (Munich). 2007. PMID: 17634873 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters